These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Quantitation of Urinary Acylcarnitines by DMS-MS/MS Uncovers the Effects of Total Body Irradiation in Cancer Patients. Vera NB; Coy SL; Laiakis EC; Fornace AJ; Clasquin M; Barker CA; Pfefferkorn JA; Vouros P J Am Soc Mass Spectrom; 2020 Mar; 31(3):498-507. PubMed ID: 32013416 [TBL] [Abstract][Full Text] [Related]
43. The Use of DMS-MS for the Quantitative Analysis of Acylcarnitines. Vera NB; Clasquin M; Coy SL; Vouros P Methods Mol Biol; 2020; 2084():95-101. PubMed ID: 31729655 [TBL] [Abstract][Full Text] [Related]
44. Isolation and identification of alpha-methyloctanylcarnitines from human urine. Kerner J; Bieber LL Prep Biochem; 1985; 15(4):237-57. PubMed ID: 3003725 [TBL] [Abstract][Full Text] [Related]
45. Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease. Millington DS; Roe CR; Maltby DA Biomed Mass Spectrom; 1984 May; 11(5):236-41. PubMed ID: 6743766 [TBL] [Abstract][Full Text] [Related]
46. Post-mortem recognition of inherited metabolic disorders from specific acylcarnitines in tissue in cases of sudden infant death. Roe CR; Millington DS; Maltby DA; Wellman RB Lancet; 1987 Feb; 1(8531):512. PubMed ID: 2881073 [No Abstract] [Full Text] [Related]
47. Application of continuous-flow liquid chromatography/fast-atom bombardment mass spectrometry to the analysis of diagnostic acylcarnitines in human urine. Norwood DL; Kodo N; Millington DS Rapid Commun Mass Spectrom; 1988 Dec; 2(12):269-72. PubMed ID: 2577839 [TBL] [Abstract][Full Text] [Related]
48. Age-related variations in acylcarnitine and free carnitine concentrations measured by tandem mass spectrometry. Cavedon CT; Bourdoux P; Mertens K; Van Thi HV; Herremans N; de Laet C; Goyens P Clin Chem; 2005 Apr; 51(4):745-52. PubMed ID: 15708951 [TBL] [Abstract][Full Text] [Related]
50. Matrix-assisted laser desorption/ionization for simultaneous quantitation of (acyl-)carnitines and organic acids in dried blood spots. Ostermann KM; Dieplinger R; Lutsch NM; Strupat K; Metz TF; Mechtler TP; Kasper DC Rapid Commun Mass Spectrom; 2013 Jul; 27(13):1497-504. PubMed ID: 23722684 [TBL] [Abstract][Full Text] [Related]
51. Rapid determination of C4-acylcarnitine and C5-acylcarnitine isomers in plasma and dried blood spots by UPLC-MS/MS as a second tier test following flow-injection MS/MS acylcarnitine profile analysis. Forni S; Fu X; Palmer SE; Sweetman L Mol Genet Metab; 2010 Sep; 101(1):25-32. PubMed ID: 20591710 [TBL] [Abstract][Full Text] [Related]
52. Isotope Labeling Strategies for Acylcarnitines Profile in Biological Samples by Liquid Chromatography-Mass Spectrometry. Li S; Gao D; Song C; Tan C; Jiang Y Anal Chem; 2019 Feb; 91(3):1701-1705. PubMed ID: 30636414 [TBL] [Abstract][Full Text] [Related]
53. High-performance liquid chromatography of coenzyme A esters formed by transesterification of short-chain acylcarnitines: diagnosis of acidemias by urinary analysis. Dugan RE; Schmidt MJ; Hoganson GE; Steele J; Gilles BA; Shug AL Anal Biochem; 1987 Feb; 160(2):275-80. PubMed ID: 3578754 [TBL] [Abstract][Full Text] [Related]
54. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Roe CR; Hoppel CL; Stacey TE; Chalmers RA; Tracey BM; Millington DS Arch Dis Child; 1983 Nov; 58(11):916-20. PubMed ID: 6651329 [TBL] [Abstract][Full Text] [Related]
55. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. Roe CR; Millington DS; Maltby DA J Clin Invest; 1986 Apr; 77(4):1391-4. PubMed ID: 3958190 [TBL] [Abstract][Full Text] [Related]
56. Determination of urinary acylcarnitines by ESI-MS coupled with solid-phase microextraction (SPME). Möder M; Löster H; Herzschuh R; Popp P J Mass Spectrom; 1997 Nov; 32(11):1195-204. PubMed ID: 9373960 [TBL] [Abstract][Full Text] [Related]
57. A clinically validated method to separate and quantify underivatized acylcarnitines and carnitine metabolic intermediates using mixed-mode chromatography with tandem mass spectrometry. Luna C; Griffin C; Miller MJ J Chromatogr A; 2022 Jan; 1663():462749. PubMed ID: 34954532 [TBL] [Abstract][Full Text] [Related]
58. Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome. Bene J; Márton M; Mohás M; Bagosi Z; Bujtor Z; Oroszlán T; Gasztonyi B; Wittmann I; Melegh B Ann Nutr Metab; 2013; 62(1):80-5. PubMed ID: 23296094 [TBL] [Abstract][Full Text] [Related]
59. Serum and urine total, free and acylcarnitine levels related to age: assessment of renal handling of carnitine. Güneral F Turk J Pediatr; 1995; 37(3):217-22. PubMed ID: 7502358 [TBL] [Abstract][Full Text] [Related]
60. Urinary propionylcarnitine analysis for monitoring carnitine supplementation in inherited disorders of propionate metabolism. Sugiyama N; Matsuda I; Wada Y; Narisawa K; Kobayashi M; Kidouchi K J Inherit Metab Dis; 1994; 17(5):611-5. PubMed ID: 7837769 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]